Zobrazeno 1 - 10
of 205
pro vyhledávání: '"N. Obukhova"'
Autor:
A. N. Vasileva, O. A. Aleshina, E. S. Kotova, B. V. Biderman, T. N. Obukhova, I. V. Galtseva, V. N. Dvirnyk, E. I. Zakharko, A. B. Sudarikov, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 19, Iss 2, Pp 14-25 (2024)
Background. Current chemotherapy protocols for T-cell acute lymphoblastic leukemia (T-ALL) allow achieving a 5-year overall survival of 60–90 %, but relapsed and refractory forms remain incurable situations.Aim. To determine the significance of imm
Externí odkaz:
https://doaj.org/article/adedd1175d824e51baec49dd4a48c0c7
Autor:
B. D. Chaltsev, A. V. Torgashina, A. M. Lila, T. V. Markova, S. I. Kutsev, O. P. Ryzhkova, A. A. Orlova, A. V. Kokhno, T. I. Solovyova, V. N. Dvirnyk, A. M. Kovrigina, T. N. Obukhova, E. N. Parovichnikova, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 92-101 (2023)
This article presents the first case of VEXAS syndrome identified in the Russian Federation as well as characteristics of currently known clinical manifestations and treatment approaches. The clinical observation described is an impressive example of
Externí odkaz:
https://doaj.org/article/384c3eebf67e4465a4859c058c2a6f75
Autor:
G. N. Obukhova
Publikováno v:
Правоприменение, Vol 7, Iss 3, Pp 135-144 (2023)
The subject. Proclaiming the ideas of partnership and solidarity, the state designates a completely new development focused on socio-economic relations in Russia, involving new principles of interaction between society, business and the state. The re
Externí odkaz:
https://doaj.org/article/28ecd799f31e483e937c50f99dd45a70
Autor:
K. A. Pekhova, Yu. V. Sidorova, N. A. Severina, O. A. Glinshchikova, I. S. Fevraleva, B. V. Biderman, Yu. A. Chabaeva, S. M. Kulikov, I. A. Luk’yanova, A. I. Kashlakova, T. N. Obukhova, V. N. Dvirnyk, A. B. Sudarikov
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 102-114 (2023)
Background. Tumor cell proliferation in acute myeloid leukemia (AML) may manifest with high leukocyte counts. In our work, we evaluate the association of high leukocyte counts with individual mutations, as well as their total contribution to the deve
Externí odkaz:
https://doaj.org/article/f6c43010c61f498ebdddc2d3c851444f
Autor:
O. A. Aleshina, I. V. Galtseva, E. S. Kotova, G. I. Isinova, T. N. Obukhova, V. N. Dvirnik, A. B. Sudarikov, M. E. Grishunina, O. S. Samoilova, K. D. Kaplanov, V. A. Lapin, S. N. Bondarenko, E. S. Fokina, N. V. Minaeva, T. S. Konstantinova, Yu. V. Sveshnikova, E. E. Zinina, A. S. Antipova, O. Yu. Baranova, E. A. Borisenkova, Yu. O. Davydova, N. M. Kapranov, S. M. Kulikov, Yu. A. Chabaeva, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 18, Iss 1, Pp 20-30 (2023)
Background. The effectiveness of therapy for acute T-lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL) has significantly improved over the past decades, including through the implementation of hematopoietic stem cell transplantation
Externí odkaz:
https://doaj.org/article/ae6ce0a734c64904adb16a244596e630
Autor:
M. V. Firsova, N. V. Risinskaya, M. V. Solovev, T. N. Obukhova, M. A. Kislitsyna, E. E. Nikulina, I. A. Yakutik, T. V. Abramova, A. B. Sudarikov, A. M. Kovrigina, L. P. Mendeleeva
Publikováno v:
Онкогематология, Vol 17, Iss 4, Pp 67-80 (2022)
Background. Multiple myeloma complicated by extramedullary plasmacytoma is an unfavorable variant of the disease. It remains unknown what triggers tumor transformation. The review presents literature data on the pathogenesis of extramedullary disease
Externí odkaz:
https://doaj.org/article/4378015c43324b289afbe3c4858fbd00
Autor:
A. I. Zakharova, T. N. Obukhova
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 17-23 (2022)
Molecular-genetic markers are the most important prognostic factors of B-cell chronic lymphocytic leukemia (B-CLL). These markers are VH mutational status, it’s surrogate markers — СD38, ZAP-70, LPL и ADAM29 and the aim of this study - cytogene
Externí odkaz:
https://doaj.org/article/46c4536954d74224acba2ec533dae0a9
Autor:
E. S. Kotova, O. A. Gavrilina, I. A. Yakutik, A. B. Sudarikov, Yu. A. Chabaeva, S. M. Kulikov, S. G. Beksaev, V. V. Troitskaya, G. A. Isinova, A. N. Sokolov, Z. T. Fidarova, I. A. Lukyanova, A. V. Abramova, V. N. Dvirnyk, I. V. Galtseva, T. N. Obukhova, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 98-107 (2022)
Background. 6-mercaptopurine (6-MP) is a drug that is included in the treatment protocols for children and adults with acute lymphoblastic leukemias/lymphomas (ALL/LBL). It is known that individual differences in 6-MP tolerance can be explained by th
Externí odkaz:
https://doaj.org/article/258f0daa502345c7a75d1d9529faa844
Autor:
A. D. Yudina, S. V. Vanyakina, E. V. Tush, T. I. Eliseeva, A. N. Obukhova, D. V. Baratynskiy, N. Yu. Geraskina, A. V. Stroganov, O. V. Khaletskaya
Publikováno v:
Аллергология и Иммунология в Педиатрии, Vol 0, Iss 3, Pp 63-64 (2023)
Externí odkaz:
https://doaj.org/article/e33668f57cbb4f67bed889aa73b3953d
Autor:
Elena N. Parovichnikova, Irina A. Lukianova, Vera V. Troitskaya, Mikhail Yu. Drokov, Larisa A. Kuzmina, Andrei N. Sokolov, Alina V. Kokhno, Zalina T. Fidarova, Irina V. Galtseva, Yuliya O. Davydova, Anastasiia I. Kashlakova, Elena O. Gribanova, Eugene E. Zvonkov, Elena P. Sysoeva, Valentina N. Dvirnyk, Tatiana N. Obukhova, Andrei B. Sudarikov, Yuliya V. Sidorova, Sergei M. Kulikov, Yuliia A. Chabaeva, Valerii G. Savchenko
Publikováno v:
Терапевтический архив, Vol 93, Iss 7, Pp 753-762 (2021)
Aim. To analyze the results of treatment in patients with acute myeloid leukemia (AML) within protocols AML-17 and modified AML-17 (mOML-17) as part of two consecutive pilot studies in order to develop the best treatment strategy for AML patients age
Externí odkaz:
https://doaj.org/article/ead7e57f92e747e7b74baee842d7e924